RN Mobile Menu

Search form




In response to a study published in the journal Heart that suggested a link between calcium supplementation and an increased risk of heart attack, the National Osteoporosis Foundation stated that the findings are inconclusive and that more research is needed to better understand the potential relationship between calcium supplements and heart attack risk.

Recent years have witnessed tremendous advances in the field of orthopedic surgery, particularly in total joint arthroplasty.

Women who experience early menopause are almost twice as likely to have osteoporosis and are at greater risk for fracture and death than women who experience menopause later in life, according to results of a 34-year study conducted in Sweden.

The first generic versions of Boniva (ibandronate) tablets, a once-monthly product for managing or preventing osteoporosis in postmenopausal women, have received FDA approval.

(AUDIO) Data from a long-term prospective study reveal that, for many older women, the pace of bone mass deterioration takes place on the scale of decades, not single years. Here, the lead author of the study describes how to interpret the results to choose the date for your own patient's next bone-density test.

Osteoporosis would develop in fewer than 10% of older, postmenopausal women during rescreening intervals of about 15 years for those with normal bone density or mild osteopenia, 5 years for those with moderate osteopenia, and 1 year for those with advanced osteopenia, according to a study reported in The New England Journal of Medicine.

Decreases in bone mineral density and an increased risk of arthritis may be linked to bilateral oophorectomy, according to new research presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.


Subscribe to Osteoporosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.